Literature DB >> 15824070

TGF-beta signaling regulates CD8+ T cell responses to high- and low-affinity TCR interactions.

Wajahat Z Mehal1, Shehzad Z Sheikh, Leonid Gorelik, Richard A Flavell.   

Abstract

Absence of transforming growth factor-beta (TGF-beta) signaling to T cells in mice results in an increase in T cell numbers, an activated CD44 high, CD69-, CD25- T cell phenotype and a T cell-mediated injury to many organs. It is not known if such T cell activation in the absence of TGF-beta signaling is spontaneous or due to aberrant T cell responses to a physiological stimulus. We used adoptive transfer of CD8+ T cells from mice double transgenic for the OT-1 TCR and the TGF-beta1-dominant negative transgene [OT-dominant-negative receptor (DNR)] to investigate the role of TGF-beta in regulating CD8+ T cell activation in vivo. The activation and expansion of single-transgenic OT and double-transgenic OT-DNR cells to oral antigens, high-affinity and low-affinity peptides were indistinguishable. Activation with high-affinity peptide and CFA however resulted in greater expansion of OT-DNR cells in comparison to OT cells. Low-affinity peptide and adjuvant did not result in OT cell activation or expansion but results in up-regulation of CD44 on OT-DNR cells. These data show that TGF-beta functions in vivo to limit the scale of CD8+ T cell expansion after high-affinity peptide-MHC interactions. TGF-beta also limits T cell activation to the highest affinity peptide-MHC interactions. The increase in T cell number and activation present in TGF-beta-deficient and TGF-beta DNR-expressing mice may be due to the loss of these two phenomena.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15824070     DOI: 10.1093/intimm/dxh233

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  6 in total

1.  Differential IL-2 expression defines developmental fates of follicular versus nonfollicular helper T cells.

Authors:  Daniel DiToro; Colleen J Winstead; Duy Pham; Steven Witte; Rakieb Andargachew; Jeffrey R Singer; C Garrett Wilson; Carlene L Zindl; Rita J Luther; Daniel J Silberger; Benjamin T Weaver; E Motunrayo Kolawole; Ryan J Martinez; Henrietta Turner; Robin D Hatton; James J Moon; Sing Sing Way; Brian D Evavold; Casey T Weaver
Journal:  Science       Date:  2018-09-14       Impact factor: 47.728

2.  TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis.

Authors:  Daniele V F Tauriello; Sergio Palomo-Ponce; Diana Stork; Antonio Berenguer-Llergo; Jordi Badia-Ramentol; Mar Iglesias; Marta Sevillano; Sales Ibiza; Adrià Cañellas; Xavier Hernando-Momblona; Daniel Byrom; Joan A Matarin; Alexandre Calon; Elisa I Rivas; Angel R Nebreda; Antoni Riera; Camille Stephan-Otto Attolini; Eduard Batlle
Journal:  Nature       Date:  2018-02-14       Impact factor: 49.962

3.  Attenuation of TGF-β signaling supports tumor progression of a mesenchymal-like mammary tumor cell line in a syngeneic murine model.

Authors:  Tanuka Biswas; Xiang Gu; Junhua Yang; Lesley G Ellies; Lu-Zhe Sun
Journal:  Cancer Lett       Date:  2013-12-22       Impact factor: 8.679

4.  T-cell TGF-β signaling abrogation restricts medulloblastoma progression.

Authors:  David Gate; Moise Danielpour; Javier Rodriguez; Gi-Bum Kim; Rachelle Levy; Serguei Bannykh; Joshua J Breunig; Susan M Kaech; Richard A Flavell; Terrence Town
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-31       Impact factor: 11.205

5.  TGF-β sensitivity restrains CD8+ T cell homeostatic proliferation by enforcing sensitivity to IL-7 and IL-15.

Authors:  Lisa D S Johnson; Stephen C Jameson
Journal:  PLoS One       Date:  2012-08-06       Impact factor: 3.240

6.  Transforming Growth Factor-beta signaling in αβ thymocytes promotes negative selection.

Authors:  Mark J McCarron; Magali Irla; Arnauld Sergé; Saidi M'Homa Soudja; Julien C Marie
Journal:  Nat Commun       Date:  2019-12-19       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.